The State of Economic Evaluation in Vision Research—Adding a fourth for bridge

Kymes, Steve

doi:10.3109/09286586.2014.988878

Cited by 1 publication

(3 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, given their sensitivity and responsiveness, the suitability of existing generic quality of life instruments like EQ-5D, to measure the impact of vision and its deterioration on quality of life, has been debated. 24,25 Others 26 were concerned with how to measure quality of life over the duration of a disease – particularly when quality of life may be affected greater in the later stages of diseases. They also had concerns with respect to gathering evidence with ethical concerns regarding the use of randomized controlled trials and the procurement of sufficient sample sizes.…”

Section: Discussionmentioning

confidence: 99%

“…Kymes 24 questioned how deteriorating vision and its impact on quality of life should be measured appropriately. Furthermore, given their sensitivity and responsiveness, the suitability of existing generic quality of life instruments like EQ-5D, to measure the impact of vision and its deterioration on quality of life, has been debated.…”

Section: Challenges In Implementing Economic Evaluations And/or Healtmentioning

confidence: 99%

“…It has been suggested that ophthalmological economic evaluations and health technology assessments incorporate synergies created from simultaneously screening for multiple diseases in primary care; as well as patient preferences and simultaneously consider the cost effectiveness of preventative care. 24 Capturing and valuing such synergies, along with incorporating preventative care and patient preferences are priorities for all clinical areas. There is an opportunity for ophthalmology to lead the way in how to achieve these priorities.…”

Section: Opportunities For Implementing Economic Evaluations And/or Hmentioning

confidence: 99%

See 2 more Smart Citations

Health technology assessment: A primer for ophthalmology

Murphy

McElnea

Byrne³

2018

European Journal of Ophthalmology

View full text Add to dashboard Cite

Rising healthcare costs and increasing demands for health care require techniques to choose between competing uses and even rationing of health care. Economic evaluations and health technology assessments are increasingly a means to assess the cost effectiveness of healthcare interventions so as to inform such resource allocation decisions. To date, the adoption of health technology assessments, as a way of assessing cost effectiveness, in ophthalmology has been slower, relative to their implementation in other specialities. Nevertheless, demands for eye services are increasing due to an ageing population. The prevalence of conditions such as glaucoma, cataract, diabetic eye disease and age-related macular degeneration increases with age, and it is predicted that global blindness will triple by 2050. So there is a challenge for ophthalmologists to ensure that they can contribute to, interpret, critically evaluate, and use findings from economic evaluations in their clinical practice. To aid this, this article serves as a primer on the use of health technology assessments to assess cost effectiveness using economic evaluation techniques for ophthalmologists. Healthcare systems face many challenges worldwide - changing demographics and evolution of new technologies are only going to intensify. With this in mind, ophthalmology needs to be ready and able to engage with health economists to prepare, interpret, critically evaluate and use findings of economic evaluations and health technology assessments.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Challenges In Implementing Economic Evaluations And/or Healtmentioning

confidence: 99%

Section: Opportunities For Implementing Economic Evaluations And/or Hmentioning

confidence: 99%

See 1 more Smart Citation